Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials

Gerding, DN, Cornely, OA, Grill, S et al. (11 more authors) (2019) Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials. The Lancet Infectious Diseases, 19 (3). pp. 265-274. ISSN 1473-3099

Abstract

Metadata

Authors/Creators:
  • Gerding, DN
  • Cornely, OA
  • Grill, S
  • Kracker, H
  • Marrast, AC
  • Nord, CE
  • Talbot, GH
  • Buitrago, M
  • Gheorghe Diaconescu, I
  • Murta de Oliveira, C
  • Preotescu, L
  • Pullman, J
  • Louie, TJ
  • Wilcox, MH https://orcid.org/0000-0002-4565-2868
Copyright, Publisher and Additional Information: © 2019 Elsevier Ltd. This is an author produced version of a paper published in The Lancet Infectious Diseases. Uploaded in accordance with the publisher's self-archiving policy.
Dates:
  • Published: March 2019
  • Accepted: 20 September 2018
  • Published (online): 29 January 2019
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Molecular Gastroenterology (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 18 Feb 2019 12:55
Last Modified: 29 Jul 2019 00:45
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/s1473-3099(18)30614-5
Related URLs:

Share / Export

Statistics